Search results

The Medical Cannabis Clinicians Society (MCCS) has published its first comprehensive guidance specifically for pharmacy professionals involved in the dispensing of cannabis-based medicinal products (CBPMs) in the UK. Pharmacists play a vital role in the dispensing of CBPMs and have a...

The first academic research on Switzerland’s landmark adult-use pilot, has reported a decline in problematic consumption, particularly among those who used other drugs in addition to cannabis. Europe’s first adult-use cannabis pilot programme, the Weed Care study, launched in Basel...

Denmark has officially passed legislation which will solidify its long-running medical cannabis pilot programme as a permanent fixture of its national healthcare system in what has been described as a ‘victory for patients’. First announced in November 2024, the medical cannabis bill (L135) has...

Despite being one of the most important regulatory systems in human physiology, the endocannabinoid system (ECS) remains inexplicably absent from almost all mainstream medical education. A report published by Volteface in 2022 found that in the UK, while around 40,000 clinicians are eligible to...

The ‘remarkable’ mother and campaigner, who played a pivotal role in the legalisation of medical cannabis in the UK, Hannah Deacon, has died at the age of 45. In a statement on her website, Hannah’s loved ones said they were ‘heartbroken’ to share the news of her death after a ‘short and brutal...

New analysis from the UK has found that cannabis-based medicines are associated with improvements in symptoms and overall quality of life in patients with treatment-resistant epilepsy. Researchers say the study, which analysed data from the UK Medical Cannabis Registry (UKMCR), shows the...

After a six-year battle on behalf of campaigners, Romania’s Health Committee has rejected a bill which would broaden access to medical cannabis products on prescription. Following what has been described as “six years of silence”, in February, Romania’s Health Committee of the Chamber...

New research reveals that the use of cannabidiol (CBD) cannabis extract can lead to meaningful benefits and improve behaviour in children and teenagers with autism spectrum disorder (ASD). ASD affects approximately one in 100 children around the world and symptoms can include difficulty...

A new pilot study has examined how medically supervised cannabis use in a residential recovery home may support people in treatment for substance use challenges. The study, recently published in the Journal of Studies on Alcohol and Drugs, was conducted by researchers from UBC Okanagan and...

A cannabis executive is calling for law enforcement agencies to be better educated on medical cannabis, after a court ruled UK border force officers wrongfully seized his prescription. The managing director of the Canndr medical cannabis platform has spoken publicly for the first time after...

The largest meta-analysis of scientific data on medical cannabis’ viability in cancer treatment to date has been published, finding overwhelmingly positive consensus for its therapeutic potential. In a comprehensive review drawing on a dataset of over 10,000 peer-reviewed publications and...

Patients prescribed medical cannabis in Australia maintained improvements in overall health-related quality of life (HRQL), fatigue, and sleep disturbance across a one-year period, according to new research. The study, published in the journal PLOS One by researchers at the University of...

The number of pregnant women using cannabis in the US has more than tripled over the last two decades, with researchers calling for further studies to inform intervention approaches. Cannabis use has been increasing during pregnancy, according to researchers at Columbia University Mailman...

Scientists at the University of South Australia say they have developed an innovative solution to improve the effectiveness of cannabidiol to treat epilepsy, multiple sclerosis and other neurodegenerative diseases. Cannabidiol (CBD), the non-psychoactive compound found in the cannabis plant, is...

France’s four-year campaign to launch a fully regulated generalised medical cannabis framework is finally being realised. Just weeks ago thousands of participants in Frances’ medical cannabis ‘experiment’, launched in 2021, were preparing to wean themselves off the treatment and had been...

UK adults remain confused about the legal status and availability of medical cannabis, despite it being legalised in 2018, a new survey has revealed. According to a new study of 2,000 adults, while four in every five respondents (79%) were aware of medical cannabis, only 26% of people know...

Releaf is one of the first medical cannabis clinics to integrate with the NHS’ Spine service, the digital backbone of healthcare across the UK. Could this be a turning point in how clinicians view and engage with cannabis-based medicines? While the number of prescriptions for CBMPs is growing...

Last week, the 68th session of the United Nations Commission on Narcotic Drugs (CND) voted almost unanimously to place hexahydrocannabinol (HHC) under Schedule II of the 1971 Convention. After over a year of warnings from various international health bodies and individual efforts from a swathe...

A new study has found certain cannabis terpenes to be effective at relieving post-surgical and fibromyalgia pain in preclinical models. Research from the University of Arizona Health Sciences and funded by the National Institute of Health, suggests that terpenes from the Cannabis sativa plant...

Written by SOMAÍ Pharmaceuticals CEO, Michael Sassano For years, medical cannabis has been treated as a commodity, with little emphasis on brand differentiation. However, as the market evolves, established cannabis brands are playing an increasingly critical role in patient care, physician...